MedMen Enterprises, Inc. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD from Q2 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
MedMen Enterprises, Inc. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and growth rate from Q2 2019 to Q1 2023.
  • MedMen Enterprises, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending March 25, 2023 was -$357M, a 44.6% decline year-over-year.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 -$357M -$110M -44.6% Mar 25, 2023 10-Q 2023-07-10
Q4 2022 -$325M -$106M -48.4% Dec 24, 2022 10-Q 2023-07-10
Q3 2022 -$310M -$109M -54% Sep 24, 2022 10-Q 2023-07-10
Q2 2022 -$319M -$64.9M -25.6% Jun 26, 2022 10-Q 2022-11-03
Q1 2022 -$247M -$24.8M -11.1% Mar 26, 2022 10-Q 2023-07-10
Q4 2021 -$219M +$27.6M +11.2% Dec 25, 2021 10-Q 2023-07-10
Q3 2021 -$201M -$8.7M -4.53% Sep 25, 2021 10-Q 2023-07-10
Q2 2021 -$254M -$76.7M -43.4% Jun 27, 2021 10-Q 2022-11-03
Q1 2021 -$222M -$372M -249% Mar 27, 2021 10-Q 2022-05-10
Q4 2020 -$247M Dec 26, 2020 10-Q 2022-02-08
Q3 2020 -$192M Sep 26, 2020 10-Q 2021-11-09
Q2 2020 -$177M -$388M -184% Jun 27, 2020 10-K 2022-09-09
Q1 2020 $150M Mar 28, 2020 10-Q 2021-05-12
Q2 2019 $211M Jun 29, 2019 10-K 2021-09-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.